BEDMINSTER, NJ, Oct 10, 2011 (MARKETWIRE via COMTEX) —
The American Diabetes Association is honoring Integrium Clinical
Research at its 16th annual gala on November 5 at the Grounds for
Sculpture in Hamilton, New Jersey. The gala not only recognizes
leaders and pioneering researchers in diabetes but also aims to raise
funds needed to expand and continue outreach programs in New Jersey.
Integrium is a contract research organization (CRO) with a
therapeutic focus on cardiovascular and metabolic diseases. Executive
Director of the American Diabetes Association in New Jersey, Mathieu
N. Nelessen says Integrium earned this honor for its successful
efforts to speed the development of new and more effective drug
treatment for diabetes.
Integrium has conducted 18 clinical trials of treatment for diabetes
at 557 study sites. In addition to trials targeting diabetes,
Integrium has conducted more than 100 cardiovascular and renal
disease trials, which have an impact on diabetes care since diabetes
is a leading cause of kidney failure and more than two-thirds of
people with diabetes die of heart disease or stroke.
Integrium founder Dr. David H. G. Smith observes that the diabetes
epidemic is not abating. “A staggering 366 million people worldwide
suffer from diabetes. One in ten American adults has diabetes and
that number may triple in the coming decades. The disease is the
seventh leading cause of death in the U.S. More than half a million
people in New Jersey have been diagnosed with diabetes and an
estimated 200,000 have diabetes but have not yet been diagnosed.”
About Diabetes
The United States is in the throes of a diabetes epidemic. An
estimated 24 million children and adults have diabetes. Another 57
million others have pre-diabetes, elevated blood glucose levels that
increase their risk of developing diabetes, heart disease and stroke.
Diabetes is a leading cause of kidney failure, blindness, amputations
and pregnancy complications and is the seventh leading cause of death
in the U.S. Timely diagnosis and effective treatment help to prevent
and reduce the symptoms and life-threatening complications of
diabetes.
About the American Diabetes Association
The American Diabetes Association funds research to prevent, cure and
manage diabetes; deliver services to hundreds of communities; provide
objective and credible information and; is the voice for persons
denied their rights because of diabetes.
About Integrium, LLC.
Integrium is a full-service clinical research organization (CRO)
designing, conducting, and analyzing clinical trials for
pharmaceutical research in dermatology, cardiovascular, and metabolic
disorders. It is committed to focused, specialized, and long-term
personalized service to its partners. It has a strong reputation for
delivering high-quality management of clinical development programs.
Combining the Integrium Clinical Excellence (ICE) study start-up and
management methodology and therapeutic expertise leads sponsors to
more confident, better-informed drug and device development
decisions. For more information please visit
http://www.integrium.com .
Eileen McAuley
908-375-2005
Email Contact
SOURCE: Integrium
http://www2.marketwire.com/mw/emailprcntct?id=FF3A337BC1EB8ED2
Copyright 2011 Marketwire, Inc., All rights reserved.
